AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Merck to create separate cancer division as Keytruda patent loss looms - Reuters

Merck to create separate cancer division as Keytruda patent loss looms - Reuters

Merck to create separate cancer division as Keytruda patent loss looms Reuters

February 23, 2026 at 11:22 AM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

United States

Tags

cancer keytruda merck patent pharmaceuticals

All Coverage

Merck to create separate cancer division as Keytruda patent loss looms - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxQU1BzQ29nR09oYWZJSTNRMW1wQy1uZHdPZmFvNGRYRk5LbUY0RWpkLXlfSjluMW9ubTJEUFZ1Ymc5ZHdrR2hxWEVud1VVdEI0ZkktREcyNW85ZFVPRHdHYnBlYnZ5aTM2ZlFsdGpCVU9WaE9lb29nd0VGdXlZeGVIYWYwZlRsT1RxOUp2akR1VWo3QVM4MWVOTEMtQnN6TmZfcHJ2X1p4TkdIcHpRUUpSMjJyTm8wSllOSDdpd2pvRlRKSG51azlSU0Y4TmhqeU9KM1R4NElVOEQ4TEpmaGhEZXpLUQ?oc=5" target="_blank">Merck to create separate cancer division as Keytruda patent loss looms</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters

Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough Reuters

August 28, 2026 at 11:32 AM

GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters

GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters

August 24, 2026 at 07:11 AM

Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters

Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters

August 25, 2026 at 06:00 PM

Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters

Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters

August 26, 2026 at 06:18 PM

US FDA approves Takeda, Protagonist's drug for rare blood cancer - Reuters

US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters

August 28, 2026 at 10:16 PM

The Merck/Moderna cancer vaccine: How does it work and what are potential barriers to wide use? - Reuters

The Merck/Moderna cancer vaccine: How does it work and what are potential barriers to wide use? Reuters

August 25, 2026 at 04:32 PM